Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study. After ...

Three immigrant parents with backgrounds in tech are running for two spots on the board of the Mountain View-Los Altos High School District. Li Zhang, Vadim Katz and Alexandra Levich are the ...

Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary ...

– Strong cash position expected to fund Alto’s planned operations through multiple near-term milestones across pipeline of independent programs – MOUNTAIN VIEW, Calif., October 22, 2024 ...